These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 6573959)

  • 1. Combination of vindesine and prednisone in malignant lymphoma and acute leukemia.
    Raich PC; Walker BK; Rogers JS; Subramanian VP; Fontana JA; Knost JA; Denning B
    Cancer Treat Rep; 1983 May; 67(5):485-7. PubMed ID: 6573959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
    Ueda T; Masaoka T; Shibata H; Kubota Y; Saigo K; Kusakabe H; Takubo T; Nakamura H; Yoshitake J; Ishigami S
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phase II study of vindesine in hematological malignancies].
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vindesine-prednisone in the treatment of blast crisis of chronic myeloid leukemia.
    Lemoine F; Najman A; Laporte JP; Gorin NC; Duhamel G
    Cancer Treat Rep; 1985 Feb; 69(2):203-4. PubMed ID: 3855698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A randomized controlled study on vindesine and vincristine in combination with prednisolone in the treatment of adult acute lymphocytic leukemia and blastic crisis of chronic myeloid leukemia].
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2500-8. PubMed ID: 6580840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
    Maraninchi D; Gastaut JA; Tubiana N; Carcassonne Y
    Bull Cancer; 1981; 68(4):338-42. PubMed ID: 6947833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)].
    Marthé G; Misset JL; de Vassal F; Hayat M; Gouveia J; Machover D; Belpomme D; Schwarzenberg L; Ribaud P; Pico JL; Musset M; Jasmin C; de Luca L
    Nouv Presse Med; 1978 Feb; 7(7):525-8. PubMed ID: 273888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with VM-26, adriamycin bleomycin, and prednisone as a secondary treatment of malignant lymphoma.
    Goldhirsch A; Pirovino M; Sonntag RW; Tschopp L; Ryssel HJ; Brunner KW
    Cancer Treat Rep; 1980; 64(2-3):335-7. PubMed ID: 6157468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic myeloid leukemia blast crisis with vindesine and prednisone.
    Jehn U; Mezger J
    Cancer Treat Rep; 1985 Apr; 69(4):445-8. PubMed ID: 3857971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of chronic myelogenous leukemia in blastic crisis--vindesine, cytosine arabinoside prednisolone combination therapy].
    Uzuka Y; Saito Y; Takahash H; Komatsu M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1064-70. PubMed ID: 6586112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine.
    Mathé G; Misset JL; De Vassal F; Gouveia J; Hayat M; Machover D; Belpomme D; Pico JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; De Luca L
    Cancer Treat Rep; 1978 May; 62(5):805-9. PubMed ID: 274996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of vindesine in patients with hematological malignancies.
    Hulhoven R; Michaux JL; Cornu G; Ferránt A; Bosly A; Delannoy A; Sokal G
    Biomedicine; 1980 Apr; 33(2):31-2. PubMed ID: 6931617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase II study of the treatment of CML blast crisis with vindesine and prednisone].
    Jehn U; Mezger J
    Onkologie; 1984 Dec; 7(6):342-5. PubMed ID: 6396561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vindesine, carmustine, doxorubicin, and prednisone (EBAP) in recurrent lymphomas: a Southwest Oncology Group study.
    Weick JK; Jones SE; Grozea PN; Fabian CJ; Dixon DO
    Cancer Treat Rep; 1984; 68(7-8):963-7. PubMed ID: 6744347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m-AMSA: phase II trial in advanced lymphoma and leukemia.
    Case DC
    Am J Clin Oncol; 1984 Aug; 7(4):357-60. PubMed ID: 6588746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of vindesine in patients with acute leukemia.
    Sklaroff RB; Arlin Z; Young CW
    Cancer Treat Rep; 1979; 63(11-12):2063-5. PubMed ID: 294307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of the blast crisis in chronic myeloid leukemia. Results of a phase II study with vindesine].
    Hellriegel KP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):699-706. PubMed ID: 6172337
    [No Abstract]   [Full Text] [Related]  

  • 18. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
    Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
    Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase II study of Vindesine in patients with hematological malignancy].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1536-7. PubMed ID: 6347082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic myelogenous leukemia in blastic crisis with chemotherapy incorporating vindesine-prednisolone.
    Uzuka Y; Saito Y
    Cancer Treat Rep; 1985 Nov; 69(11):1297-9. PubMed ID: 3867403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.